key: cord-0728638-ht8deqi0
authors: Saleem, Ayesha; Sajid, Mir Ibrahim; Arshad, Muhammad
title: Acute Appendicitis during SARS-CoV-2: A Brief Communication of Patients and Changes in Clinical Practice from a Single Institute in Pakistan
date: 2020-08-05
journal: J Pediatr Surg
DOI: 10.1016/j.jpedsurg.2020.07.033
sha: 1ce517b275e941f8d3333a9caa5aa7ef19160060
doc_id: 728638
cord_uid: ht8deqi0

nan

We read the paper "Limiting hospital resources for acute appendicitis in children: Lessons learned from the U.S. epicenter of the COVID-19 pandemic" by Dr. Charlotte L Kvasnovsky and colleagues [1] with great interest and would like to comment on our institutional experience with regards to the management of pediatric patients presenting to our center with acute appendicitis during SARS-CoV-2.

The policies for managing pediatric surgery patients were developed by surgical and anesthesia teams collectively with consultations from our hospital's infectious diseases (ID) department, and the following principles were implemented: 1) All elective surgical procedures were suspended to preserve hospital workforce and maintain sufficient capacity to deal with any surge in SARS-CoV-2 cases. 2) In order to protect both the patients and the healthcare staff, tele-medicine clinics were introduced. Only those patients who required post-operative evaluation were seen in the outpatient clinic.

3) The patients and their caregivers were screened for SARS-CoV-2, according to the protocol designated by the hospital's ID team, prior to their visit to the hospital and on arrival to the clinic. 4) In children who exhibited no clinical or radiological indication, of complicated appendicitis, they were given an intravenous trial of antibiotics -as an alternative to surgery.

In the past two months since these policies were implemented, the pediatric surgery team has managed twelve patients-their details given in Table 1 . The mean age of the patients was 8.8 years (1.5-14) , mean time between the development of symptoms of appendicitis and receiving medical treatment was 3.3 days (1-7), and mean length of hospital admission 6.6 days (0-20). We found 3 (25%) of the managed patients were positive for SARS-CoV-2 on PCR test. It is worthwhile to note that 7 (58.3%) of the patients presented with a perforated appendix-the highest percentage observed in a cohort of patients over a two-month timespan at our hospital. This is a significant increase from the prior years.

However, significant challenges were faced while implementing these policies. These included:

1) A decrease in volume of patients operated because of: a) Lockdown policies restricting access to the hospital b) Fear of an epidemiological SARS-CoV-2 infection while visiting the hospital -resulting in a greater incidence of complicated cases. c) Reduction in operation theatre slots to preserve our healthcare workforce (6 slots per week to 2 slots per week) 2) Patients leaving the hospital against medical advice when counselled regarding the policy of mandatory SARS-CoV-2 testing prior to surgery. Three patients Left Against Medical Advice after having a confirmed diagnosis of acute appendicitis. This comes amidst fear of getting positive SARS-CoV-2 test and the stigma associated with it. 3) A decrease in patients seen in the tele-clinics because of scarce access to necessary technology to schedule an appointment, e.g. internet, laptop and smart phones. Per ACCME regulations, in order to provide Continuous Medical Educational credit, the Journal of Pediatric Surgery must ensure that anyone who is in a position to control the content of the education activity has disclosed to us all relevant financial relationships with any commercial interest (see below for definitions).

X None of the authors have anything to disclose (if you are the corresponding author).

List the names of any proprietary entities producing marketing, re-selling, or distributing health care goods or services consumed by, or used on patients with which you or your spouse/partner have, or have had, a relevant financial relationship within the past 12 months. 

Explain what you or your spouse/partner received (ex: salary, honorarium etc).  Specify your role. Through our review process, should it be determined that a bias is apparent within the content of the article, you will be requested to revise your manuscript prior to publication.

If your article describes the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage, it is your responsibility to disclose this information within the manuscript.

A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Limiting hospital resources for acute appendicitis in children: Lessons learned from the U.S. epicenter of the COVID-19 pandemic